This Special Report clearly explains the principles of data exclusivity and the complex law surrounding this fast-changing area of intellectual property. Of special relevance to the pharmaceutical and biotech sectors, the work examines the legislative framework and recent case law to provide the practitioner with a comprehensive guide to maximising the protection of test data and data generated from clinical trials. * The only detailed study of this rapidly developing area * A one-stop guide, including commentary as well as legislative and case law materials * Important international perspective, comparing the legal regime in key jurisdictions.